419 — Birmingham, Alabama

419 is a clinical research site located in Birmingham, Alabama, United States.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

419 has participated in 2 clinical trials.

Therapeutic areas: Early Stage Parkinson's Disease, Early Stage Parkinson Disease.

Sponsors: Solvay Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 419?

419 has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 419 conducted?

419 has 2 clinical trials on record. Their work covers Early Stage Parkinson's Disease, Early Stage Parkinson Disease.

Is 419 accredited by Crixeo Health?

419 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 419?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.